EDGAR Filing Documents for 0001171843-18-006663

Form POS AM - Post-Effective amendments for registration statement:

SEC Accession No. 0001171843-18-006663

Filing Date

2018-09-21

Accepted

2018-09-21 16:16:18

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	POS AM	posam_092118.htm	POS AM	79435
2	EXHIBIT 23.1	exh_231.htm	EX-23.1	7084
3	GRAPHIC	logo.jpg	GRAPHIC	8438
4	GRAPHIC	kpmg.jpg	GRAPHIC	29438
	Complete submission text file	0001171843-18-006663.txt		139678

Mailing Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3

Business Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3 450-686-4555

Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)